Clinical Trial Update: The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register

View source ↗

Summary

This clinical trial registry update announces the establishment of a Hong Kong register for metabolic dysfunction-associated steatotic liver disease in people w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Type 2 Diabetes (T2DM) | Status: RECRUITING